Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Pemvidutide: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after Pemvidutide therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to Pemvidutide overviewDuring Treatment (4 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| ALT/AST | → normalizes | Every 12 weeks |
| Body Weight | ↓ decreases | Every 12 weeks |
| Liver Fat (MRI-PDFF) | ↓ decreases | Every 24 weeks |
| HbA1c | ↓ decreases | Every 12 weeks |